https://www.oncolens.com/resources/ 2021-09-25T22:28:15+00:00 https://www.oncolens.com/casestudy/bon-secours-supportive-care-referrals/ 2026-07-13T16:07:00+00:00 https://www.oncolens.com/blog/closing-the-biomarker-gap/ 2026-05-29T03:51:22+00:00 https://www.oncolens.com/casestudy/tampa-general-hospital-oncology-analytics/ 2026-05-29T03:50:03+00:00 https://www.oncolens.com/blog/advancing-coc-lung-cancer-quality-standards/ 2026-03-30T15:14:42+00:00 https://www.oncolens.com/education/streamline-your-cancer-registry-with-oncolens-and-crstar/ 2025-10-07T13:08:09+00:00 https://www.oncolens.com/casestudy/a-new-era-in-trial-matching-real-time-oncology-data-to-drive-enrollment/ 2025-09-23T19:23:19+00:00 https://www.oncolens.com/casestudy/how-one-cancer-center-found-14-missed-patients-with-the-oncolens-registry-report/ 2025-09-23T19:19:00+00:00 https://www.oncolens.com/casestudy/how-real-time-referral-data-transformed-breast-cancer-care-at-a-leading-academic-center/ 2025-09-23T15:15:11+00:00 https://www.oncolens.com/blog/precision-in-the-wild-finding-and-addressing-the-needle-in-the-haystack/ 2025-09-23T15:14:09+00:00 https://www.oncolens.com/casestudy/oncology-focused-ai-llm-to-find-right-patients-for-your-clinical-trials/ 2025-08-21T19:42:51+00:00 https://www.oncolens.com/casestudy/oncolens-connects-cancer-programs-and-life-science-organizations-to-increase-guideline-based-biomarker-and-targeted-treatment-therapies/ 2025-03-31T16:11:29+00:00 https://www.oncolens.com/casestudy/results-of-a-qip-to-increase-complete-lung-cancer-biomarker-testing-rates/ 2025-03-31T15:56:03+00:00 https://www.oncolens.com/casestudy/oncolens-analytics-enables-a-350-increase-in-genetic-testing-at-community-cancer-center/ 2025-03-31T15:32:23+00:00 https://www.oncolens.com/cme/gastric-cancer-enhanced-clinical-decision-making-via-molecular-profiling/ 2025-01-10T17:08:05+00:00 https://www.oncolens.com/cme/nsclc-individualizing-care-based-on-patient-and-tumor-characteristics/ 2025-01-08T20:24:45+00:00 https://www.oncolens.com/blog/the-lung-map-trial-early-patient-tracking-for-improved-accruals/ 2024-11-06T16:39:44+00:00 https://www.oncolens.com/blog/changes_to_coc_accreditation_standards/ 2024-11-06T16:23:29+00:00 https://www.oncolens.com/news/oncology-health-tech-startup-announces-series-b-funding-round-for-continued-growth/ 2024-10-25T14:35:05+00:00 https://www.oncolens.com/news/oncolens-announces-real-time-oncology-patient-id-for-clinical-trials-and-key-services/ 2024-09-18T22:06:23+00:00 https://www.oncolens.com/news/oncolens-named-to-inc-5000-list-of-fastest-growing-private-companies-in-america/ 2024-09-18T22:00:56+00:00 https://www.oncolens.com/casestudy/improved-broad-based-ngs-testing-and-discussion-of-targeted-therapies-in-mdts/ 2024-09-17T21:28:30+00:00 https://www.oncolens.com/cme/project-echo-learning-series-evolving-role-of-bispecific-antibodies-as-cancer-therapy/ 2024-08-15T18:55:39+00:00 https://www.oncolens.com/casestudy/enhancing-guideline-based-genetic-testing-in-breast-patients-with-oncolens-advanced-patient-id/ 2024-07-10T16:24:08+00:00 https://www.oncolens.com/education/surgical-optimization-multidisciplinary-approach-to-3d-cell-culture-chemosensitivity-in-hgg-patients/ 2024-06-20T19:24:22+00:00 https://www.oncolens.com/education/revolutionizing-the-future-of-cancer-care-by-predicting-individual-patient-responses-to-oncology-drugs/ 2024-06-20T17:59:04+00:00 https://www.oncolens.com/education/hgg-webinar-series-using-patient-specific-tumor-tissue-to-predict-tumor-response-before-treatment-initiation/ 2024-06-20T17:58:55+00:00 https://www.oncolens.com/education/personalizing-treatment-in-high-grade-glioma-using-3d-ex-vivo-technology/ 2024-06-20T17:58:36+00:00 https://www.oncolens.com/education/combining-3d-cell-culture-chemosensitivity-results-and-ngs-profiles-to-maximize-outcomes-in-glioblastoma/ 2024-06-20T17:58:13+00:00 https://www.oncolens.com/cme/melanoma-oncolytic-immunotherapy-an-evolving-therapeutic-landscape/ 2024-06-06T15:36:16+00:00 https://www.oncolens.com/casestudy/qip-to-increase-complete-lung-cancer-biomarker-testing-rates/ 2024-05-31T21:41:37+00:00 https://www.oncolens.com/casestudy/improved-management-of-mcrc-through-real-world-data-insights-and-tumor-board-embedded-physician-education/ 2024-05-23T20:05:38+00:00 https://www.oncolens.com/education/liquid-biopsy-and-concurrent-testing-strategies-for-patients-with-metastatic-nsclc/ 2024-05-10T18:46:10+00:00 https://www.oncolens.com/cme/project-echo-pulmonary-toxicities-with-immune-checkpoint-inhibitors/ 2024-03-11T17:09:41+00:00 https://www.oncolens.com/cme/project-echo-dermatologic-toxicities-with-immune-checkpoint-inhibitors/ 2024-03-11T17:09:23+00:00 https://www.oncolens.com/cme/project-echo-hepatobiliary-toxicities-with-immune-checkpoint-inhibitors/ 2024-03-11T17:09:08+00:00 https://www.oncolens.com/cme/project-echo-neurological-toxicities-with-immune-checkpoint-inhibitors/ 2024-03-11T17:08:53+00:00 https://www.oncolens.com/cme/project-echo-rheumatologic-toxicities-with-immune-checkpoint-inhibitors/ 2024-03-11T17:08:39+00:00 https://www.oncolens.com/cme/project-echo-endocrine-toxicities-with-immune-checkpoint-inhibitors/ 2024-03-11T17:08:13+00:00 https://www.oncolens.com/cme/project-echo-gastroenterology-toxicities-with-immune-checkpoint-inhibitors/ 2024-03-11T17:08:01+00:00 https://www.oncolens.com/cme/project-echo-cardiovascular-toxicities-with-immune-checkpoint-inhibitors/ 2024-03-11T17:07:46+00:00 https://www.oncolens.com/cme/project-echo-tele-mentoring-to-manage-irae-in-patients-receiving-cancer-immunotherapies/ 2024-03-11T17:07:20+00:00 https://www.oncolens.com/education/quality-improvement-program-webinar-nsclc-biomarker-testing/ 2024-03-11T17:06:22+00:00 https://www.oncolens.com/education/quality-improvement-program-webinar-breast-and-ovarian-cancer-biomarker-testing/ 2024-03-11T17:06:05+00:00 https://www.oncolens.com/cme/hitting-the-benchmarks-in-mcrc-a-precision-medicine-quality-initiative-for-the-care-team/ 2024-03-11T16:59:55+00:00 https://www.oncolens.com/education/expert-insights-into-management-of-advanced-triple-negative-breast-cancer/ 2024-03-11T16:56:53+00:00 https://www.oncolens.com/education/lung-cancer-screening-and-identification-of-lung-cancer-patients-at-all-stages/ 2024-03-11T16:56:20+00:00 https://www.oncolens.com/education/optimizing-management-of-newly-diagnosed-ovarian-cancer-including-maintenance/ 2024-03-11T16:55:56+00:00 https://www.oncolens.com/blog/rapid-identification-of-cancer-patient-cohorts-and-care-patterns-with-generative-ai/ 2023-12-14T16:49:22+00:00 https://www.oncolens.com/blog/disappointing-clinical-trial-accruals-the-cancer-center-perspective/ 2023-09-18T15:00:46+00:00 https://www.oncolens.com/news/oncology-start-up-oncolens-named-to-top-10-list-of-innovative-technology-companies-in-georgia/ 2023-08-24T20:54:28+00:00 https://www.oncolens.com/news/cancer_response_to_covid/ 2023-08-24T20:51:27+00:00 https://www.oncolens.com/news/new-markey-initiative-helps-affiliates-deliver-cancer-care-closer-to-home/ 2023-08-24T20:50:12+00:00 https://www.oncolens.com/news/oncolens-celebrates-the-cocs-100th-anniversary/ 2023-08-24T20:49:52+00:00 https://www.oncolens.com/news/oncolens-platform-critical-to-meeting-the-cocs-continuous-quality-improvement-requirements/ 2023-08-24T20:49:07+00:00 https://www.oncolens.com/news/the-desmoid-tumor-research-foundation-closes-care-gaps-through-virtualized-multidisciplinary-cancer-care-platform/ 2023-08-24T20:48:36+00:00 https://www.oncolens.com/news/mib-agents-selects-oncolens-to-support-and-expand-its-turbo-program-globally/ 2023-08-24T20:48:15+00:00 https://www.oncolens.com/news/accc-and-boston-university-present-the-project-echo-eight-part-webinar-series-powered-by-oncolens/ 2023-08-24T20:47:26+00:00 https://www.oncolens.com/news/oncolens-connects-best-cancer-care-minds-therapies-innovations-in-time-to-make-a-difference/ 2023-08-24T20:46:20+00:00 https://www.oncolens.com/news/oncolens-welcomes-cross-border-impact-ventures-fund-as-capital-partner-to-fuel-international-growth/ 2023-08-24T18:51:38+00:00 https://www.oncolens.com/blog/strategies-for-enhancing-hospital-programs-accreditation-quality-metric-tracking/ 2023-08-10T14:11:16+00:00 https://www.oncolens.com/blog/the-trend-of-clinical-trials-in-the-community-setting/ 2023-07-17T02:40:36+00:00 https://www.oncolens.com/education/building-and-engaging-affiliate-cancer-care-networks-webinar/ 2023-05-31T02:50:56+00:00 https://www.oncolens.com/education/ovarian-and-lung-cancer-patients-with-brca-reversion-and-3-egfr-mutations/ 2023-04-20T03:29:17+00:00 https://www.oncolens.com/education/nccn-updates-stage-ib-iia-nsclc-with-egfr-alteration-patients/ 2023-04-20T03:27:36+00:00 https://www.oncolens.com/education/patient-with-stage-ib-nsclc-an-oncocyte-determarx-high-risk-result-and-an-egfr-exon-19-deletion/ 2023-04-20T03:25:16+00:00 https://www.oncolens.com/education/overview-of-new-coc-standards/ 2023-04-20T03:22:33+00:00 https://www.oncolens.com/education/lung-cancer-patient-with-3-egfr-mutations/ 2023-04-20T03:18:45+00:00 https://www.oncolens.com/education/ovarian-cancer-patient-with-somatic-brca1-reversion-mutation/ 2023-04-20T03:18:26+00:00 https://www.oncolens.com/education/stage-ia3-patient-with-egfr-exon-19-deletion-alteration-and-high-risk-determarx-result/ 2023-04-20T03:17:19+00:00 https://www.oncolens.com/education/nsclc-patient-and-adjuvant-chemotherapy/ 2023-04-20T03:16:54+00:00 https://www.oncolens.com/education/patient-with-possible-synchronous-early-stage-nsclc-and-different-determarx-results/ 2023-04-20T03:16:31+00:00 https://www.oncolens.com/education/patient-with-nsclc-who-recurred-within-a-year/ 2023-04-20T03:14:42+00:00 https://www.oncolens.com/education/stratification-of-early-stage-non-squamous-nsclc-patients-likely-to-benefit-from-early-post-operative-chemotherapy/ 2023-04-20T03:10:36+00:00 https://www.oncolens.com/education/mtc-patient-with-stomach-cancer-and-kit-exon-11-and-atm-mutations/ 2023-04-20T03:09:34+00:00 https://www.oncolens.com/education/patient-with-prostate-cancer-and-cdk12-and-tp53-mutations/ 2023-04-20T03:06:45+00:00 https://www.oncolens.com/education/mtb-discussion-for-patients-with-kit-and-cdk12-mutations/ 2023-04-20T03:02:20+00:00 https://www.oncolens.com/cme/optimizing-frontline-immunotherapy-in-advanced-non-small-cell-lung-cancer/ 2023-04-20T02:29:30+00:00 https://www.oncolens.com/cme/molecular-testing-in-the-community-oncology-setting/ 2023-04-20T02:18:22+00:00 https://www.oncolens.com/news/breaking-down-silos-in-cancer-care/ 2023-03-27T23:23:55+00:00 https://www.oncolens.com/casestudy/mainegeneral/ 2023-03-05T20:27:43+00:00 https://www.oncolens.com/blog/oncolens-and-cancer-centers-overcome-clinical-trial-patient-recruitment-challenges/ 2023-03-05T20:25:53+00:00 https://www.oncolens.com/blog/oncolens-empowers-mtbs/ 2023-01-27T04:52:30+00:00 https://www.oncolens.com/blog/oncolens-streamlines-naprc-accreditation-through-advanced-patient-tracking-and-analytics-reporting/ 2023-01-19T23:04:11+00:00 https://www.oncolens.com/news/vtbdemos24/ 2022-10-14T17:29:11+00:00 https://www.oncolens.com/news/women-led-digital-health/ 2022-09-30T21:45:56+00:00 https://www.oncolens.com/casestudy/ascension-lourdes/ 2022-07-19T03:33:42+00:00 https://www.oncolens.com/casestudy/greatlakeshealthsystem/ 2022-07-19T03:31:58+00:00 https://www.oncolens.com/blog/2022-multidisciplinary-cancer-care-top-five-trends/ 2022-01-25T18:28:42+00:00 https://www.oncolens.com/casestudy/multidisciplinary-conference-quality-measurement-tool-implementation-results/ 2021-12-03T17:55:09+00:00 https://www.oncolens.com/casestudy/time-saving-opportunities-through-tumor-board-and-cancer-registry-integration/ 2021-12-03T17:32:35+00:00 https://www.oncolens.com/news/four-factors-affecting-the-post-covid-cancer-care-landscape/ 2021-12-03T17:09:15+00:00 https://www.oncolens.com/news/barbaraannkarmanoscancerinstitute/ 2021-10-17T22:19:44+00:00 https://www.oncolens.com/blog/esmo_2019_highlights_breast_cancer/ 2021-10-16T19:01:57+00:00 https://www.oncolens.com/blog/healthcare-technology-changing-demographic/ 2021-10-16T19:01:03+00:00 https://www.oncolens.com/blog/vtb_security/ 2021-10-16T18:57:13+00:00 https://www.oncolens.com/blog/naprc-tumor-board/ 2021-10-16T18:55:57+00:00 https://www.oncolens.com/casestudy/wellstar_aligns_with_oncolens_for_efficiencies_and_naprc_accreditation/ 2021-10-16T18:54:25+00:00 https://www.oncolens.com/casestudy/evolving-the-tumor-board-experience/ 2021-10-16T18:51:31+00:00 https://www.oncolens.com/news/telehealth/ 2021-10-16T18:26:49+00:00 https://www.oncolens.com/casestudy/harold-leever-cancer-center-streamlines-cancer-conferences/ 2021-10-16T18:20:38+00:00 https://www.oncolens.com/news/series_a_funding/ 2021-10-16T17:32:40+00:00